NPCE Insider Trading

Insider Ownership Percentage: 22.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $59,691,383.20

NeuroPace Insider Trading History Chart

This chart shows the insider buying and selling history at NeuroPace by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$40M-$20M$0$20M$40MTotal Insider BuyingTotal Insider Selling

NeuroPace Share Price & Price History

Current Price: $13.28
Price Change: Price Increase of +0.17 (1.30%)
As of 04/2/2025 03:57 PM ET

This chart shows the closing price history over time for NPCE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$13.11Closing price on 04/01/25:

SEC Filings (Institutional Ownership Changes) for NeuroPace (NASDAQ:NPCE)

78.83% of NeuroPace stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NPCE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$75Mbought$1.93MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$50M$0$50MTotal InflowsTotal Outflows
NeuroPace logo
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Read More on NeuroPace

Today's Range

Now: $13.28
Low: $12.54
High: $13.39

50 Day Range

MA: $12.64
Low: $10.04
High: $14.69

52 Week Range

Now: $13.28
Low: $5.45
High: $15.77

Volume

90,300 shs

Average Volume

129,586 shs

Market Capitalization

$432.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.06

Who are the company insiders with the largest holdings of NeuroPace?

NeuroPace's top insider investors include:
  1. Ltd Kck (Major Shareholder)
  2. Orbimed Advisors Llc (Major Shareholder)
  3. Martha Morrell (Insider)
Learn More about top insider investors at NeuroPace.